COLLABRX, INC.
44 Montgomery Street, Suite 800
San Francisco, California  94104
 
 
November 20, 2014
 
 
By EDGAR Transmission

 
 
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Attention:  Gabriel Eckstein
 
Re: CollabRx, Inc.:  Registration Statement on Form S-1 (File No. 333-199477)

Ladies and Gentlemen:
 
On November 18, 2014, in accordance with Rule 461 of the General Rules and Regulations of the Securities Act of 1933, as amended (the “Securities Act”), CollabRx, Inc. (the “Company”) requested acceleration of the effective date of the above-referenced Registration Statement on Form S-1 so that it might be declared effective at 5 p.m. (Washington, DC time), November 20, 2014, or as soon as practicable thereafter.
 
We would like to withdraw that request at this time.
 
If you have any questions regarding this request, please contact William Davisson of Goodwin Procter LLP at (650) 752-3114.
 
 
 
Sincerely,
     
     
 
COLLABRX, INC
     
     
 
By:
/s/ Thomas R. Mika
  Name:  Thomas R. Mika
  Title:  President & Chief Executive Officer


cc:            William Davisson, Esq.